Compass Therapeutics | IPO Presentation Deck | 40 slides · page 13 of 40
The slide uses a molecular structure diagram to illustrate the binding site differences between CTX-471 and existing therapies.
Pitch deck · solution · present_solution · dense density
Slide locked Sign in to view
Slide schematic 7/7
image 1/1 list 3/3 paragraph 1/1 source-note 1/1 title 1/1
Components 7
illustration bullet bullet bullet paragraph source-note headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.